Novartis reported a 43.1% jump in net profit to Rs 9.70 crore in Q4 FY21 compared with Rs 6.78 crore in Q4 FY20.
Net sales grew 6% to Rs 99.29 crore in Q4 FY21 compared with Rs 93.70 crore in Q4 FY20. Profit before tax stood at Rs 21.9 crore in Q4 FY21, up 61.6% over Rs 13.55 crore in Q4 FY20.The pharma company reported a 107% jump in net profit to Rs 20.9 crore for the year ended March 2021 (FY21) compared with Rs 10.08 crore in the year ended March 2020 (FY20). Revenue from operations declined nearly 13% to Rs 381.35 crore in FY21 over FY20.
Meanwhile, the board has recommended a final dividend of Rs 10 per share for FY20.
Novartis India manufactures drugs, medicines and allied products. The company globally is focused on three divisions - pharmaceuticals, eye care and generic medicines.
Shares of Novartis were down 5.45% at Rs 820.10 on BSE.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app